Ligand validation:6ZVX

OEH: [9-[2-carboxy-5-[2-[2-(6-chloranylhexoxy)ethoxy]ethylcarbamoyl]phenyl]-6-(dimethylamino)xanthen-3-ylidene]-dimethyl-azanium

OEH is a Ligand Of Interest in 6ZVX designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZVX_OEH_A_301	93%	42%	0.073	0.966	1.13	1.12	4	5	0	0	100%	0.9778
6ZVY_OEH_B_303	76%	41%	0.1	0.936	1.23	1.08	4	4	0	0	100%	0.9778
7ZIV_OEH_A_301	75%	55%	0.103	0.935	1.02	0.72	4	2	2	0	100%	0.272
6ZVV_OEH_B_301	73%	42%	0.09	0.917	1.3	0.97	4	3	0	0	100%	0.9778
6ZVU_OEH_A_301	66%	39%	0.111	0.915	1.29	1.09	5	5	0	0	100%	0.9778
6ZVW_OEH_B_303	58%	41%	0.114	0.893	1.22	1.1	5	6	0	0	100%	0.9778
8B6S_OEH_B_601	91%	56%	0.078	0.965	0.99	0.72	4	1	0	0	100%	0.9778

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.